SNTI
NKTX

Rajangam Kanya

Known title: Chief Medical & Devt. OfficerCIK: 0001816676

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

SNTI Included in List of Health Care Stocks Moving Pre-Market. Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.

this person other insiders at SNTI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

Nkarta Sets 2026 Data Reveal as CAR NK Trials Progress. Nkarta announced that it is targeting a data reveal for its outpatient CAR NK trials in 2026. The company said the trials are advancing, indicating progress toward a potential regulatory milestone. This development may influence how the market views the company’s future prospects. The stock is currently trading near its support level of $2.61.

this person other insiders at NKTX

Transaction History

SNTI▼ Sell$0
SNTI▼ Sell$0
SNTI▼ Sell$74K
SNTI▲ Buy$0
SNTI▼ Sell$795
SNTI▼ Sell$5K
SNTI▲ Buy$0
NKTX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.